Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical 56-day open label, multi-center study to evaluate the PK and safety of LYR-210 in adult subjects with chronic rhinosinusitis (CRS)

Next Previous
X
Search
Trial Profile

A clinical 56-day open label, multi-center study to evaluate the PK and safety of LYR-210 in adult subjects with chronic rhinosinusitis (CRS)

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mometasone (Primary)
  • Indications Rhinosinusitis
  • Focus Pharmacokinetics
  • Sponsors Lyra Therapeutics

    • Most Recent Events

    • 01 Nov 2022 Results reporting pharmacokinetics and safety data published in the American Journal of Rhinology and Allergy
    • 30 Jun 2021 According to a Lyra Therapeutics media release, data from this trial will be presented during a podium presentation at the upcoming American Rhinologic Society Annual meeting in October 2021.
    • 30 Jun 2021 According to a Lyra Therapeutics media release, Randall Ow is investigator of this trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top